strength behavior
report solid result vs forecast
tax benefit updat guidanc brought live
final month impact util pmpm typic occur larg
number new member join platform rais revenu guidanc
narrow ebitda guidanc base result busi momentum
sell season updat focus multi-product deal global
book behavior health plan traction especi strong new teladoc
medic expert includ expert opinion complex behavior physic issu
two client live continu like tdoc broad offer
scale thwart competit secular growth stori reiter outperform
revenu adj ebitda ep revenu rose y/i
vs consensu estim guidanc adj
ebitda vs estim consensu guid
ep loss includ tax benefit vs consensu
estim guid
visit membership estim total visit
y/i vs estim guidanc total visit us paid
membership includ paid visit total visit us
vs estim
sell season updat plan intern particularli strong rfp
volum ytd book ahead deal size averag
median multi-product deal strong contributor book repres
guidanc introduc expect revenu vs
consensu estim adj ebitda seen
vs estim consensu per share loss expect
vs consensu estim share
outstand visit expect vs estim
membership detail
chang estim adjust revenues/ep benefit
guidanc revenu go ep loss
incorpor membership live lift
revenu forecast ep loss expand slightli
year price histori
wide use
telehealth provid us offer
doctor servic time
resolv common medic issu via
phone on-line video chat
analyst certif import disclosur see disclosur
rise preval high-deduct plan favor
reimburs chang increas consumer
drive growth altern care deliveri model telehealth
view current debat around subscription/pmpm
vs visit fee-onli model like continu expect
evolv market estim annual
total address market best doctor low current
penetr estim believ signific
runway growth telehealth andw expect increas
membership awar drive top-lin growth teladoc
teladoc continu take share growth telehealth market
revenu mix like chang three major contract
higher visit fee exchang lower/no pmpm per member per
meaning uptick util visit per member better
large-cli win either employ plan particularli competit
win drive member growth estim
chang healthcar drive faster expect growth telehealth
subscript pmpm fee debat subsid revenu mix slowli
shift subscription/visit fee
teladoc continu take signific share market
competit chang telehealth model pressur subscription/
new competit offer take signific share telehealth
adjust pt increas revenu estim increas pt base ev/rev prior
pt also base ev/rev continu assign premium valuat due lead posit telehealth
risk on-going debat subscript vs visit fee may lower growth margin visit-fe model
win forc navig big mix shift expect increas competit stand-alone vendor
physician advanc medic acquisit increas integr risk best doctor expert-opinion servic
revenu adj ebitda ep revenu rose y/i vs
consensu estim guid adj ebitda vs estim
consensu guid ep loss includ tax benefit vs
consensu estim guid
visit membership estim total visit y/i vs
estim guid total visit us paid membership includ paid visit
total visit us paid membership vs year-ago total us paid membership jump
y/i vs estim util annual nearli vs
last year despit onboard larg popul includ impact
pepm y/i sequenti revenu mix detail pepm
onboard last month quarter normal vs year-ago visit
revenu total total subscript access fee revenu total split
gm om gross margin vs estim year ago
cost revenu estim oper margin vs
estim year ago sale expens less expect
guidanc introduc revenu expect vs consensu
estim adj ebitda seen vs estim consensu ep
loss expect vs consensu estim share outstand
visit expect vs estim us paid membership expect vs
estim visit-fee-onli access
revenu guid rais ebitda narrow rais revenu guid
vs consensu estim adj ebitda guid narrow
vs estim consensu rais visit guidanc
vs estim us paid membership rais vs
estim visit-fe membership seen ep loss
improv vs estim consensu
share
sell season updat plan intern particularli strong rfp volum ytd
book deal size averag median multi-product deal strong contributor
except per share visit
revenu
technolog develop
gener administr
depreci amort
loss oper
provis incom tax
technolog develop
gener administr
technolog develop
gener administr
compani report oppenheim estim
